Immuno gene therapy for treatment of cancer and hyperproliferative diseases
US9468687B2 · kind B2 · utility
1Cited by
15References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2014 |
| Grant date | Oct 18, 2016 |
| Priority date | — |
| Expiry date | Apr 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/87
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising a nucleic acid, a gene delivery polymer, and at least one adjunctive chemotherapeutic drug for the treatment of mammalian cancer or hyperproliferative disorders and methods of using thereof for the treatment of mammalian cancer or hyperproliferative disorders by intratumoral, intraperitoneal or systemic injection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.